3The Rotterdam ESH RE/ASRM-Sponsored PCOS Consensus Work Shop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome ( PCOS ) [ J ]. Hum Reprod, 2004,19 ( 1 ) :41 - 47.
4Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome : the Rotterdam criteria are premature. J Clin Endocrinol Metab,2006, 91:781-785.
5Azziz R, Carmina C, Dewailly D, et al. Positions statement : criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : an Androgen Excess Society guideline. J Clin Endocrinol Metab, 2006, 91 : 4237-4245.
6Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome : in defence of the Rotterdam criteria. J Clin Endocrinol Metab, 2006, 91: 786-789.
7Carmina E, Chu MC, Longo RA, et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab, 2005, 90 : 2545-2549.
8Jakubowski L. Genetic aspects of polycystic ovary syndrome. Endokrynol Pol, 2005, 56:285-293.
